Balance Sheet Breakdown: Quantum BioPharma Ltd (QNTM)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

After finishing at $4.23 in the prior trading day, Quantum BioPharma Ltd (NASDAQ: QNTM) closed at $3.45, down -18.44%. In other words, the price has decreased by -$18.44 from its previous closing price. On the day, 0.56 million shares were traded. QNTM stock price reached its highest trading level at $5.7 during the session, while it also had its lowest trading level at $3.42.

Ratios:

Our goal is to gain a better understanding of QNTM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.76 and its Current Ratio is at 3.76. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QNTM now has a Market Capitalization of 6773005 and an Enterprise Value of -4010341.

Stock Price History:

Over the past 52 weeks, QNTM has reached a high of $70.85, while it has fallen to a 52-week low of $3.50. The 50-Day Moving Average of the stock is -30.65%, while the 200-Day Moving Average is calculated to be -77.22%.

Shares Statistics:

The stock has traded on average 81.60K shares per day over the past 3-months and 68380 shares per day over the last 10 days, according to various share statistics. A total of 1.86M shares are outstanding, with a floating share count of 1.59M. Insiders hold about 17.20% of the company’s shares, while institutions hold 2.50% stake in the company. Shares short for QNTM as of 1732838400 were 5993 with a Short Ratio of 0.07, compared to 1730332800 on 23918. Therefore, it implies a Short% of Shares Outstanding of 5993 and a Short% of Float of 0.33000002.

Most Popular